An autosomal-recessive cobblestone (type II) lissencephaly caused by biallelic loss-of-function variants in LAMB1, encoding laminin subunit beta-1, a component of the pial basement membrane. Loss of laminin beta-1 disrupts the connection between radial glial endfeet and the pial surface, allowing neurons to overmigrate beyond the first cortical layer and producing a cobblestone cortical malformation. It is distinguished from the dystroglycanopathy cobblestone malformations (Walker-Warburg syndrome, muscle-eye-brain disease) by markedly less muscular and ocular involvement, presenting instead with cortical and white-matter abnormalities, severe cerebellar dysplasia, brainstem hypoplasia, occipital encephalocele, hydrocephalus, severe developmental delay, and seizures.
Ask a research question about LAMB1-Related Cobblestone Lissencephaly. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Conditions with similar clinical presentations that must be differentiated from LAMB1-Related Cobblestone Lissencephaly:
name: LAMB1-Related Cobblestone Lissencephaly
creation_date: "2026-07-31T00:00:00Z"
category: Mendelian
synonyms:
- lissencephaly type 5
- LIS5
- cobblestone lissencephaly without muscular or eye involvement
- LAMB1-related cobblestone brain malformation
- cobblestone brain malformation without muscular or ocular abnormalities
- cystic leukoencephalopathy with cortical dysplasia
disease_term:
preferred_term: cobblestone lissencephaly without muscular or ocular involvement
term:
id: MONDO:0014077
label: cobblestone lissencephaly without muscular or ocular involvement
description: >
An autosomal-recessive cobblestone (type II) lissencephaly caused by biallelic
loss-of-function variants in LAMB1, encoding laminin subunit beta-1, a component
of the pial basement membrane. Loss of laminin beta-1 disrupts the connection
between radial glial endfeet and the pial surface, allowing neurons to overmigrate
beyond the first cortical layer and producing a cobblestone cortical malformation.
It is distinguished from the dystroglycanopathy cobblestone malformations
(Walker-Warburg syndrome, muscle-eye-brain disease) by markedly less muscular and
ocular involvement, presenting instead with cortical and white-matter
abnormalities, severe cerebellar dysplasia, brainstem hypoplasia, occipital
encephalocele, hydrocephalus, severe developmental delay, and seizures.
inheritance:
- name: Autosomal recessive
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
description: >
Reported in two families with autosomal-recessive cobblestone brain malformation
harboring homozygous deleterious LAMB1 mutations.
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Here we report homozygous deleterious mutations in LAMB1, encoding laminin subunit beta-1, in two families with autosomal-recessive COB."
explanation: Establishes autosomal-recessive inheritance from biallelic LAMB1 mutations.
genetic:
- name: LAMB1
gene_term:
preferred_term: LAMB1
term:
id: hgnc:6486
label: LAMB1
relationship_type: CAUSATIVE
notes: >
Biallelic (homozygous or compound-heterozygous) loss-of-function variants in
LAMB1 (laminin subunit beta-1) cause cobblestone brain malformation; LAMB1 is
localized to the pial basement membrane. The disorder is transmitted as an
autosomal-recessive trait, and nearly all reported families are consanguineous.
A genotype-phenotype correlation is emerging: homozygous frameshift/truncating
(complete loss-of-function) alleles produce the most severe, congenital-onset
disease, whereas missense/in-frame (hypomorphic) alleles produce milder,
sometimes adult-onset leukoencephalopathy.
variants:
- name: c.1378T>C (p.Cys460Arg)
description: >
Homozygous missense variant in an EGF-like repeat; associated with the mild,
adult-onset leukoencephalopathy end of the recessive spectrum.
type: missense
clinical_significance: LIKELY_PATHOGENIC
evidence:
- reference: PMID:32548278
reference_title: "Adult-onset leukoencephalopathy with homozygous LAMB1 missense mutation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "identified 2 potent biallelic pathogenic mutations in LAMB1 (c.1378T>C, p.Cys460Arg)"
explanation: Homozygous missense variant in a mild adult-onset case.
- name: c.2690+1G>A
description: >
Splice-site variant identified (compound heterozygous) by prenatal
whole-exome sequencing in fetuses with congenital hydrocephalus.
type: splice site
clinical_significance: LIKELY_PATHOGENIC
evidence:
- reference: PMID:35843586
reference_title: "Compound variants of FKTN, POMGNT1, and LAMB1 gene identified by prenatal whole-exome sequencing in three fetuses with congenital hydrocephalus."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "c.2690+1G>A/c.1447C>T(p.Arg483Cys) in LAMB1 were detected in the three fetuses."
explanation: Compound-heterozygous LAMB1 variants detected prenatally in congenital hydrocephalus.
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Here we report homozygous deleterious mutations in LAMB1, encoding laminin subunit beta-1, in two families with autosomal-recessive COB."
explanation: Identifies LAMB1 as the causal gene.
- reference: PMID:32548278
reference_title: "Adult-onset leukoencephalopathy with homozygous LAMB1 missense mutation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Taken together, the effect of missense mutations on the phenotype may be milder compared with that of frameshift mutations."
explanation: Supports the genotype-phenotype correlation (missense milder than frameshift).
- reference: PMID:32548278
reference_title: "Adult-onset leukoencephalopathy with homozygous LAMB1 missense mutation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "She was born to consanguineous parents"
explanation: Illustrates the consanguineous background typical of reported families.
pathophysiology:
- name: Laminin Beta-1 Deficiency in the Pial Basement Membrane
conforms_to: "pial_basement_membrane_radial_glial_endfoot_failure#Pial Basement Membrane Assembly Failure"
biological_scale: MOLECULAR
description: >
LAMB1 encodes laminin subunit beta-1, a structural component of the pial
basement membrane. Deleterious LAMB1 mutations reduce or abolish functional
laminin beta-1, weakening the pial basement membrane.
biological_processes:
- preferred_term: basement membrane organization
term:
id: GO:0071711
label: basement membrane organization
modifier: DECREASED
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "LAMB1 is localized to the pial basement membrane"
explanation: Localizes LAMB1 to the pial basement membrane, the site of the primary defect.
downstream:
- target: Pial Basement Membrane Breach
- name: Pial Basement Membrane Breach
conforms_to: "pial_basement_membrane_radial_glial_endfoot_failure#Pial Basement Membrane Breach"
biological_scale: TISSUE
description: >
Loss of laminin beta-1 weakens the pial basement membrane / glia limitans,
producing discontinuities (breaches) in the barrier that normally prevents
neurons and glia from migrating past the pial surface.
locations:
- preferred_term: pia mater
term:
id: UBERON:0002361
label: pia mater
biological_processes:
- preferred_term: basement membrane organization
term:
id: GO:0071711
label: basement membrane organization
modifier: DYSREGULATED
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "LAMB1 is localized to the pial basement membrane, suggesting that defective connection between radial glial cells and the pial surface mediated by LAMB1 leads to this malformation."
explanation: >
Loss of LAMB1 in the pial basement membrane disrupts the barrier, the
central boundary defect that permits downstream overmigration.
downstream:
- target: Radial-Glial Basal Endfoot Detachment
- name: Radial-Glial Basal Endfoot Detachment
conforms_to: "pial_basement_membrane_radial_glial_endfoot_failure#Radial-Glial Basal Endfoot Detachment"
biological_scale: CELLULAR
description: >
A defective LAMB1-mediated connection between radial glial cells and the pial
surface detaches the radial-glial basal endfeet from the disrupted basement
membrane, collapsing the radial scaffold that guides neuronal migration.
cell_types:
- preferred_term: cortical radial glial cell
term:
id: CL:0013000
label: forebrain radial glial cell
biological_processes:
- preferred_term: formation of radial glial scaffolds
term:
id: GO:0021943
label: formation of radial glial scaffolds
modifier: DYSREGULATED
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "defective connection between radial glial cells and the pial surface mediated by LAMB1"
explanation: >
The radial glial cell-to-pial-surface connection fails, i.e. the basal
endfeet detach from the pial basement membrane.
downstream:
- target: Neuronal Overmigration Through the Pial Surface
- name: Neuronal Overmigration Through the Pial Surface
conforms_to: "pial_basement_membrane_radial_glial_endfoot_failure#Neuronal Overmigration Across the Pial Boundary"
biological_scale: CELLULAR
description: >
With the pial limiting membrane and radial scaffold disrupted, migrating
neurons protrude beyond the first cortical layer at the pial surface.
cell_types:
- preferred_term: radial glial cell
term:
id: CL:0000681
label: radial glial cell
biological_processes:
- preferred_term: neuron migration
term:
id: GO:0001764
label: neuron migration
modifier: ABNORMAL
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Cobblestone brain malformation (COB) is a neuronal migration disorder characterized by protrusions of neurons beyond the first cortical layer at the pial surface of the brain."
explanation: Defines the overmigration phenotype underlying cobblestone malformation.
downstream:
- target: Cobblestone Cortical Malformation
- name: Cobblestone Cortical Malformation
conforms_to: "pial_basement_membrane_radial_glial_endfoot_failure#Cobblestone-Like Cortical Malformation and PMG Overlap"
biological_scale: TISSUE
description: >
Neuronal overmigration produces a cobblestone (type II) cortical malformation
with cortical gyral and white-matter signal abnormalities, accompanied by
severe cerebellar dysplasia and brainstem hypoplasia.
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Affected individuals displayed a constellation of brain malformations including cortical gyral and white-matter signal abnormalities, severe cerebellar dysplasia, brainstem hypoplasia, and occipital encephalocele"
explanation: Describes the cobblestone cortical malformation and associated brain anomalies.
- reference: PMID:29888467
reference_title: "Bilateral cerebellar cysts and cerebral white matter lesions with cortical dysgenesis: Expanding the phenotype of LAMB1 gene mutations."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Muscular involvement is absent"
explanation: >
The cobblestone malformation in LAMB1 disease occurs without muscular
involvement, distinguishing it from the alpha-dystroglycanopathy congenital
muscular dystrophies (Walker-Warburg syndrome, muscle-eye-brain disease).
downstream:
- target: Hydrocephalus and Impaired CSF Dynamics
- name: Hydrocephalus and Impaired CSF Dynamics
biological_scale: ORGANISM
description: >
The abnormal cortical/leptomeningeal architecture and associated CNS
malformation disrupt CSF dynamics, producing the congenital/infantile
hydrocephalus characteristic of the disorder; this is the principal
surgically treatable consequence (CSF diversion by shunting).
biological_processes:
- preferred_term: cerebrospinal fluid circulation
term:
id: GO:0090660
label: cerebrospinal fluid circulation
modifier: DYSREGULATED
evidence:
- reference: PMID:32548278
reference_title: "Adult-onset leukoencephalopathy with homozygous LAMB1 missense mutation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "LAMB1 mutation was originally reported to cause autosomal recessive cobblestone brain malformation, presenting with congenital hydrocephalus, severe developmental delay, and an increased head circumference."
explanation: Congenital hydrocephalus is a defining organ-level consequence of the malformation.
phenotypes:
- name: Cobblestone lissencephaly
category: Neurological
phenotype_term:
preferred_term: Type II lissencephaly
term:
id: HP:0007260
label: Type II lissencephaly
description: >
Cobblestone (type II) lissencephaly with neuronal overmigration beyond the
pial surface.
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Cobblestone brain malformation (COB) is a neuronal migration disorder characterized by protrusions of neurons beyond the first cortical layer at the pial surface of the brain."
explanation: Cobblestone brain malformation is a type II lissencephaly.
- name: Cerebellar dysplasia
category: Neurological
phenotype_term:
preferred_term: Cerebellar dysplasia
term:
id: HP:0007033
label: Cerebellar dysplasia
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Affected individuals displayed a constellation of brain malformations including cortical gyral and white-matter signal abnormalities, severe cerebellar dysplasia, brainstem hypoplasia, and occipital encephalocele"
explanation: Severe cerebellar dysplasia is a core feature.
- name: Brainstem hypoplasia
category: Neurological
phenotype_term:
preferred_term: Hypoplasia of the brainstem
term:
id: HP:0002365
label: Hypoplasia of the brainstem
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "cortical gyral and white-matter signal abnormalities, severe cerebellar dysplasia, brainstem hypoplasia, and occipital encephalocele"
explanation: Brainstem hypoplasia is part of the malformation constellation.
- name: Occipital encephalocele
category: Neurological
phenotype_term:
preferred_term: Occipital encephalocele
term:
id: HP:0002085
label: Occipital encephalocele
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "severe cerebellar dysplasia, brainstem hypoplasia, and occipital encephalocele"
explanation: Occipital encephalocele reported in affected individuals.
- name: Abnormal cerebral white matter
category: Neurological
phenotype_term:
preferred_term: Abnormal cerebral white matter morphology
term:
id: HP:0002500
label: Abnormal cerebral white matter morphology
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Affected individuals displayed a constellation of brain malformations including cortical gyral and white-matter signal abnormalities"
explanation: White-matter signal abnormalities are part of the phenotype.
- reference: PMID:29888467
reference_title: "Bilateral cerebellar cysts and cerebral white matter lesions with cortical dysgenesis: Expanding the phenotype of LAMB1 gene mutations."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "LAMB1 gene analysis should be considered for intellectually disabled patients with cerebellar cysts, white matter signal change, and cortical malformation."
explanation: Confirms white-matter signal change as a recurrent LAMB1 feature.
- name: Hydrocephalus
category: Neurological
phenotype_term:
preferred_term: Hydrocephalus
term:
id: HP:0000238
label: Hydrocephalus
evidence:
- reference: PMID:37466007
reference_title: "Novel homozygous LAMB1 in-frame deletion in a pediatric patient with brain anomalies and cerebrovascular event."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Biallelic pathogenic variants in LAMB1 have been associated with autosomal recessive lissencephaly 5 (OMIM 615191), which is characterized by brain malformations (cobblestone lissencephaly, hydrocephalus), developmental delay, and epilepsy."
explanation: Hydrocephalus is a defining brain malformation of LIS5.
- name: Seizures
category: Neurological
phenotype_term:
preferred_term: Seizure
term:
id: HP:0001250
label: Seizure
evidence:
- reference: PMID:37466007
reference_title: "Novel homozygous LAMB1 in-frame deletion in a pediatric patient with brain anomalies and cerebrovascular event."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "which is characterized by brain malformations (cobblestone lissencephaly, hydrocephalus), developmental delay, and epilepsy."
explanation: Epilepsy is a core clinical feature of LAMB1-related lissencephaly 5.
- reference: PMID:33542858
reference_title: "Biallelic Variants in LAMB1 Causing Hydranencephaly: A Severe Phenotype of a Rare Malformative Encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Previously, LAMB1 -associated phenotype consisted of cobblestone lissencephaly and hydrocephalus, developmental delay, and seizures."
explanation: Seizures are part of the established LAMB1 phenotype.
- name: Global developmental delay
category: Neurological
phenotype_term:
preferred_term: Global developmental delay
term:
id: HP:0001263
label: Global developmental delay
evidence:
- reference: PMID:37466007
reference_title: "Novel homozygous LAMB1 in-frame deletion in a pediatric patient with brain anomalies and cerebrovascular event."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we report on a 6-year-old patient from a consanguineous family with profound developmental delay, microcephaly, and a history of a perinatal cerebrovascular event."
explanation: Profound developmental delay is a consistent feature.
- name: Cerebellar cysts
category: Neurological
phenotype_term:
preferred_term: Cerebellar cyst
term:
id: HP:0002350
label: Cerebellar cyst
evidence:
- reference: PMID:29888467
reference_title: "Bilateral cerebellar cysts and cerebral white matter lesions with cortical dysgenesis: Expanding the phenotype of LAMB1 gene mutations."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "LAMB1 gene analysis should be considered for intellectually disabled patients with cerebellar cysts, white matter signal change, and cortical malformation."
explanation: Bilateral cerebellar cysts are a recognized expansion of the LAMB1 phenotype.
- reference: PMID:37466007
reference_title: "Novel homozygous LAMB1 in-frame deletion in a pediatric patient with brain anomalies and cerebrovascular event."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Brain magnetic resonance imaging (MRI) showed cerebellar cystic defects, signal intensity abnormalities, and a hypoplastic corpus callosum."
explanation: Cerebellar cystic defects on MRI corroborate this feature.
- name: Hypoplasia of the corpus callosum
category: Neurological
phenotype_term:
preferred_term: Hypoplasia of the corpus callosum
term:
id: HP:0002079
label: Hypoplasia of the corpus callosum
evidence:
- reference: PMID:37466007
reference_title: "Novel homozygous LAMB1 in-frame deletion in a pediatric patient with brain anomalies and cerebrovascular event."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Brain magnetic resonance imaging (MRI) showed cerebellar cystic defects, signal intensity abnormalities, and a hypoplastic corpus callosum."
explanation: A hypoplastic corpus callosum was documented on MRI.
- name: Intellectual disability
category: Neurological
phenotype_term:
preferred_term: Intellectual disability
term:
id: HP:0001249
label: Intellectual disability
evidence:
- reference: PMID:29888467
reference_title: "Bilateral cerebellar cysts and cerebral white matter lesions with cortical dysgenesis: Expanding the phenotype of LAMB1 gene mutations."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "LAMB1 gene analysis should be considered for intellectually disabled patients with cerebellar cysts, white matter signal change, and cortical malformation."
explanation: Intellectual disability accompanies the malformation.
- reference: PMID:32548278
reference_title: "Adult-onset leukoencephalopathy with homozygous LAMB1 missense mutation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The clinical phenotype included mild intellectual disability and spastic gait."
explanation: Milder (adult-onset) cases show mild intellectual disability.
- name: Macrocephaly
category: Neurological
description: >
Increased head circumference, typically in infancy and often driven by
hydrocephalus, is the characteristic head-size finding of the congenital form.
phenotype_term:
preferred_term: Macrocephaly
term:
id: HP:0000256
label: Macrocephaly
evidence:
- reference: PMID:32548278
reference_title: "Adult-onset leukoencephalopathy with homozygous LAMB1 missense mutation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "presenting with congenital hydrocephalus, severe developmental delay, and an increased head circumference."
explanation: Increased head circumference is part of the original congenital phenotype.
- name: Microcephaly
category: Neurological
description: >
Head size is variable; while increased head circumference is typical of the
congenital form, microcephaly has been reported in a severe cerebellar/cortical
case.
phenotype_term:
preferred_term: Microcephaly
term:
id: HP:0000252
label: Microcephaly
evidence:
- reference: PMID:37466007
reference_title: "Novel homozygous LAMB1 in-frame deletion in a pediatric patient with brain anomalies and cerebrovascular event."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we report on a 6-year-old patient from a consanguineous family with profound developmental delay, microcephaly, and a history of a perinatal cerebrovascular event."
explanation: Microcephaly reported in a severely affected patient.
- name: Stroke
category: Neurological
phenotype_term:
preferred_term: Perinatal cerebrovascular event
term:
id: HP:0001297
label: Stroke
evidence:
- reference: PMID:37466007
reference_title: "Novel homozygous LAMB1 in-frame deletion in a pediatric patient with brain anomalies and cerebrovascular event."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "we report on a 6-year-old patient from a consanguineous family with profound developmental delay, microcephaly, and a history of a perinatal cerebrovascular event."
explanation: >
A perinatal cerebrovascular event (the title finding of the cited report)
suggests vascular fragility as part of the LAMB1 basement-membrane defect.
- name: Hydranencephaly
category: Neurological
description: >
At the most severe (biallelic null) end of the spectrum, LAMB1 can cause fetal
hydranencephaly incompatible with life.
phenotype_term:
preferred_term: Hydranencephaly
term:
id: HP:0002324
label: Hydranencephaly
evidence:
- reference: PMID:33542858
reference_title: "Biallelic Variants in LAMB1 Causing Hydranencephaly: A Severe Phenotype of a Rare Malformative Encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Herein we present LAMB1 as a monogenic cause of fetal hydranencephaly which was incompatible with life."
explanation: Marks the severe/lethal end of the LAMB1 phenotypic spectrum.
prevalence:
- population: Worldwide
measure_type: CASES_IN_LITERATURE
prevalence_class: ULTRA_RARE
notes: >
Very rare; as of 2023 only ~11 pathogenic LAMB1 variants and 11 patients had
been reported in the literature.
evidence:
- reference: PMID:37466007
reference_title: "Novel homozygous LAMB1 in-frame deletion in a pediatric patient with brain anomalies and cerebrovascular event."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Pathogenic variants in LAMB1 are rare, with only 11 pathogenic variants and 11 patients reported to date."
explanation: Quantifies the rarity of LAMB1-related lissencephaly 5.
treatments:
- name: Ventriculoperitoneal Shunting
description: >
Surgical CSF diversion (ventriculoperitoneal shunt) for the hydrocephalus that
is frequently congenital or infantile in this disorder. There is no
disease-modifying therapy; management of the structural malformation is
supportive and symptomatic.
therapeutic_modality: SURGERY
treatment_term:
preferred_term: ventriculoperitoneal shunt placement
term:
id: NCIT:C15329
label: Surgical Procedure
target_mechanisms:
- target: Hydrocephalus and Impaired CSF Dynamics
treatment_effect: BYPASSES
description: >
CSF diversion bypasses the impaired CSF dynamics, relieving hydrocephalus;
it is symptomatic and does not modify the upstream malformation.
- name: Encephalocele Repair
description: >
Neurosurgical repair of the occipital encephalocele when present.
therapeutic_modality: SURGERY
treatment_term:
preferred_term: surgical repair
term:
id: NCIT:C15329
label: Surgical Procedure
- name: Antiseizure Pharmacotherapy
description: >
Antiseizure medications to control the epilepsy/seizures seen in congenital
cases; agent selection follows standard pediatric epilepsy protocols, with no
LAMB1-specific drug data.
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
target_phenotypes:
- preferred_term: Seizure
term:
id: HP:0001250
label: Seizure
- name: Supportive and Rehabilitative Care
description: >
Multidisciplinary supportive care for profound neurodevelopmental disability,
including nutritional support (gastrostomy feeding in severely affected
infants), physical therapy, occupational therapy, and speech therapy.
treatment_term:
preferred_term: Supportive Care
term:
id: NCIT:C15747
label: Supportive Care
- name: Genetic Counseling
description: >
Genetic counseling for families, given the 25% recurrence risk per pregnancy
for autosomal-recessive inheritance and the frequent background of
consanguinity; enables prenatal or preimplantation testing once a familial
variant is known.
treatment_term:
preferred_term: Genetic Counseling
term:
id: NCIT:C15240
label: Genetic Counseling
imaging_findings:
- name: Cobblestone cortical malformation on MRI
modality: MRI
description: >
Brain MRI shows the cobblestone (type II) cortical pattern with gyral and
white-matter signal abnormalities, the primary diagnostic modality.
diagnostic: true
phenotype_term:
preferred_term: Type II lissencephaly
term:
id: HP:0007260
label: Type II lissencephaly
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Affected individuals displayed a constellation of brain malformations including cortical gyral and white-matter signal abnormalities, severe cerebellar dysplasia, brainstem hypoplasia, and occipital encephalocele"
explanation: MRI defines the cobblestone malformation and associated anomalies.
- name: Cerebellar cystic defects and corpus callosum hypoplasia on MRI
modality: MRI
description: >
MRI shows cerebellar cystic defects, white-matter signal-intensity
abnormalities, and a hypoplastic corpus callosum.
phenotype_term:
preferred_term: Cerebellar cyst
term:
id: HP:0002350
label: Cerebellar cyst
evidence:
- reference: PMID:37466007
reference_title: "Novel homozygous LAMB1 in-frame deletion in a pediatric patient with brain anomalies and cerebrovascular event."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Brain magnetic resonance imaging (MRI) showed cerebellar cystic defects, signal intensity abnormalities, and a hypoplastic corpus callosum."
explanation: Characteristic MRI findings in LAMB1 disease.
diagnosis:
- name: Molecular genetic testing (gene panel / whole-exome sequencing)
description: >
Diagnosis is molecular. Given phenotypic overlap with the
alpha-dystroglycanopathy cobblestone spectrum, a cobblestone-lissencephaly /
dystroglycanopathy gene panel or whole-exome/genome sequencing is used;
prenatal whole-exome sequencing is feasible when ultrasound shows congenital
hydrocephalus.
evidence:
- reference: PMID:35843586
reference_title: "Compound variants of FKTN, POMGNT1, and LAMB1 gene identified by prenatal whole-exome sequencing in three fetuses with congenital hydrocephalus."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Whole-exome sequencing (WES) has been proven to be a feasible approach for prenatal diagnosis of CH."
explanation: WES (including prenatally) is the diagnostic approach for LAMB1-related disease.
differential_diagnoses:
- name: Alpha-dystroglycanopathy cobblestone malformations
description: >
The classic cobblestone (type II) lissencephalies — Walker-Warburg syndrome,
muscle-eye-brain disease, and Fukuyama congenital muscular dystrophy — arise
from defective alpha-dystroglycan glycosylation and present with cobblestone
cortex like LAMB1 disease.
distinguishing_features:
- >-
The dystroglycanopathies feature prominent congenital muscular dystrophy
(elevated creatine kinase, abnormal EMG/NCS) and structural ocular
malformations; LAMB1-related cobblestone malformation occurs without
significant muscular or ocular involvement.
evidence:
- reference: PMID:23472759
reference_title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "but they had less apparent ocular or muscular abnormalities than are typically observed in COB."
explanation: The absence of muscle/eye involvement distinguishes LAMB1 disease.
- reference: PMID:29888467
reference_title: "Bilateral cerebellar cysts and cerebral white matter lesions with cortical dysgenesis: Expanding the phenotype of LAMB1 gene mutations."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Muscular involvement is absent, in contrast to the α-dystroglycanopathy types of congenital muscular dystrophies."
explanation: Explicitly contrasts LAMB1 disease with the dystroglycanopathies.
progression:
- phase: Congenital / infantile
notes: >
The classic form presents congenitally/in infancy with hydrocephalus and the
cobblestone malformation; the structural malformation is a fixed developmental
defect (static), with profound developmental delay and epilepsy.
evidence:
- reference: PMID:32548278
reference_title: "Adult-onset leukoencephalopathy with homozygous LAMB1 missense mutation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "presenting with congenital hydrocephalus, severe developmental delay, and an increased head circumference."
explanation: Defines the congenital-onset severe end of the course.
- phase: Adult-onset mild variant
notes: >
Hypomorphic (homozygous missense) alleles can produce a much milder,
adult-onset progressive leukoencephalopathy with migraine, gait disturbance,
and cognitive decline. Scope caveat: this milder phase lies at the boundary
of MONDO:0014077 proper — the reported adult-onset case had neither cortical
dysgenesis nor cystic lesions (i.e. no cobblestone malformation), so it
represents the hypomorphic-allele end of the LAMB1 allelic spectrum rather
than the cobblestone-defined disorder itself. Included here for
allelic-spectrum context.
evidence:
- reference: PMID:32548278
reference_title: "Adult-onset leukoencephalopathy with homozygous LAMB1 missense mutation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "We report an adulthood-onset case with mild leukoencephalopathy and a novel homozygous LAMB1 missense mutation."
explanation: Documents the mild, later-onset end of the recessive spectrum.
references:
- reference: PMID:23472759
title: "Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities."
- reference: PMID:37466007
title: "Novel homozygous LAMB1 in-frame deletion in a pediatric patient with brain anomalies and cerebrovascular event."
- reference: PMID:29888467
title: "Bilateral cerebellar cysts and cerebral white matter lesions with cortical dysgenesis: Expanding the phenotype of LAMB1 gene mutations."
- reference: PMID:33542858
title: "Biallelic Variants in LAMB1 Causing Hydranencephaly: A Severe Phenotype of a Rare Malformative Encephalopathy."
- reference: PMID:32548278
title: "Adult-onset leukoencephalopathy with homozygous LAMB1 missense mutation."
- reference: PMID:35843586
title: "Compound variants of FKTN, POMGNT1, and LAMB1 gene identified by prenatal whole-exome sequencing in three fetuses with congenital hydrocephalus."
- reference: PMID:25925986
title: "Cystic leukoencephalopathy with cortical dysplasia related to LAMB1 mutations."
discussions:
- discussion_id: gap_lamb1_pial_boundary_human_model_translatability
prompt: >-
No mouse model of laminin beta-1 loss in the pial basement membrane exists;
the rodent evidence for this entry's boundary-failure chain comes from other
laminin chains (a laminin gamma1 nidogen-binding-site deletion, and
Lamb2/Lamc3 double-null mice). Does that cross-chain evidence license the
LAMB1-specific mechanism in humans, given that laminin-chain redundancy and
heterozygous dosage sensitivity plainly differ between the two systems?
kind: HUMAN_MODEL_MISMATCH
status: OPEN
attaches_to:
- pathophysiology#Pial Basement Membrane Breach
- pathophysiology#Radial-Glial Basal Endfoot Detachment
- pathophysiology#Neuronal Overmigration Through the Pial Surface
rationale: >-
The pial-boundary mechanism this entry curates — basement-membrane
discontinuity, radial-glial endfoot retraction, and neuronal overmigration
past the pial surface — is directly demonstrated in mice, but in every
available model the perturbed subunit is a laminin chain other than beta-1:
a targeted deletion of the nidogen-binding site of laminin gamma1, and
ablation of the beta2 and gamma3 chains. For LAMB1 itself the human
mechanism is inferred from protein localization ("LAMB1 is localized to the
pial basement membrane, suggesting that defective connection ... leads to
this malformation"), not from a Lamb1 model. Two concrete mismatches follow.
First, laminin heterotrimers are combinatorial and partly redundant, so
which pial-basement-membrane functions specifically require beta-1 rather
than being buffered by another beta chain cannot be read off the gamma1 or
beta2/gamma3 models. Second, the beta2/gamma3 model is dose-sensitive —
heterozygous mice already show cortical laminar disruption — whereas human
heterozygous LAMB1 carriers are clinically and radiologically unaffected,
so mouse allele dosage does not map onto the strictly recessive human
disease. This is a model-translatability gap, not an absence of mechanism
evidence.
evidence:
- reference: PMID:12122064
reference_title: "A critical function of the pial basement membrane in cortical histogenesis."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
In segments with a disrupted basement membrane, radial glia cells were
retracted from the pial surface, and radially migrating neurons, including
Cajal-Retzius cells and cortical plate neurons, passed the meninges or
terminated their migration prematurely.
explanation: >-
Demonstrates this entry's endfoot-detachment and overmigration chain in
mouse, but in a laminin gamma1 nidogen-binding-site mutant rather than in
a Lamb1 model — the substitution that makes this a translatability gap.
- reference: PMID:22961762
reference_title: "beta2 and gamma3 laminins are critical cortical basement membrane components: ablation of Lamb2 and Lamc3 genes disrupts cortical lamination and produces dysplasia."
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Surprisingly, heterozygous mice also exhibit laminar disruption of
cortical neurons, albeit with lesser severity.
explanation: >-
The closest mouse phenocopy of cobblestone lissencephaly is dose-sensitive
in the heterozygous state, unlike the strictly recessive human LAMB1
disorder, so severity cannot be read across species.
- reference: PMID:32548278
reference_title: "Adult-onset leukoencephalopathy with homozygous LAMB1 missense mutation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Neurologic examination and brain MRI of her father showed no abnormalities"
explanation: >-
Documents an unaffected human heterozygous LAMB1 carrier, the contrast to
the heterozygous mouse laminin phenotype.
proposed_experiments:
- experiment_id: exp_lamb1_organoid_pial_ecm_chain_specificity
name: LAMB1 chain-specificity test in human cortical organoids with a pial-like ECM interface
description: >-
Build isogenic human iPSC-derived cortical organoids carrying biallelic
LAMB1 loss-of-function and hypomorphic missense alleles, cultured against
a defined laminin-rich pial-like extracellular-matrix interface, and
compare them with LAMB2 and LAMC1 perturbations in the same background.
Score basement-membrane continuity, radial-glial basal endfoot anchoring,
and neuronal overmigration past the matrix boundary, and ask whether other
beta chains compensate for beta-1 loss. Heterozygous lines are included to
test directly whether the mouse dosage sensitivity has a human counterpart.
experiment_type:
preferred_term: isogenic human cortical organoid chain-substitution experiment
model_systems:
- name: Human cortical organoid with engineered pial-like laminin ECM interface
description: >-
Human iPSC-derived cortical organoids with an engineered laminin-rich
pial-like matrix boundary, in isogenic LAMB1 wild-type, heterozygous, and
biallelic-variant states.
experimental_model_type: ORGANOID
organism:
preferred_term: human
term:
id: NCBITaxon:9606
label: Homo sapiens
tissue_term:
preferred_term: cerebral cortex
term:
id: UBERON:0000956
label: cerebral cortex
cell_types:
- preferred_term: cortical radial glial cell
term:
id: CL:0013000
label: forebrain radial glial cell
cell_source: CRISPR-engineered or patient-derived human induced pluripotent stem cells
culture_system: Three-dimensional cortical organoids at a defined laminin-rich matrix boundary
perturbations:
- name: LAMB1 allelic series with LAMB2 and LAMC1 comparators
target: pathophysiology#Laminin Beta-1 Deficiency in the Pial Basement Membrane
genes:
- preferred_term: LAMB1
term:
id: hgnc:6486
label: LAMB1
description: >-
Biallelic null, biallelic hypomorphic missense, and heterozygous LAMB1
states, with LAMB2 and LAMC1 perturbations in the same isogenic
background as chain-specificity comparators.
readouts:
- name: Basement-membrane continuity at the pial-like boundary
target: pathophysiology#Pial Basement Membrane Breach
biological_processes:
- preferred_term: basement membrane organization
term:
id: GO:0071711
label: basement membrane organization
modifier: DECREASED
direction: DECREASED
interpretation: >-
A beta-1-specific loss of continuity that other beta chains do not
rescue would establish chain specificity in a human system.
- name: Neuronal overmigration past the matrix boundary
target: pathophysiology#Neuronal Overmigration Through the Pial Surface
biological_processes:
- preferred_term: neuron migration
term:
id: GO:0001764
label: neuron migration
modifier: INCREASED
direction: INCREASED
interpretation: >-
Overmigration confined to biallelic lines, with unaffected
heterozygotes, would show that the mouse heterozygous phenotype has no
human counterpart.
decision_criterion: >-
Chain specificity is supported if biallelic LAMB1 loss breaches the
matrix boundary and drives overmigration where LAMB2 perturbation in the
same background does not; the mouse dosage mismatch is confirmed if
heterozygous LAMB1 organoids are indistinguishable from wild type.
- discussion_id: gap_lamb1_allelic_spectrum_phenotype_determinants
prompt: >-
Why does biallelic LAMB1 loss produce a phenotypic range as wide as lethal
fetal hydranencephaly, classic congenital cobblestone lissencephaly with
hydrocephalus, and adult-onset leukoencephalopathy with no cortical
dysgenesis at all — and is the truncating-versus-missense correlation this
entry records actually established, or an artifact of a cohort of about a
dozen patients?
kind: KNOWLEDGE_GAP
status: OPEN
attaches_to:
- pathophysiology#Laminin Beta-1 Deficiency in the Pial Basement Membrane
- pathophysiology#Cobblestone Cortical Malformation
rationale: >-
The reported LAMB1 phenotypic spectrum spans an extraordinary range for a
single gene: at the severe end, fetal hydranencephaly incompatible with
life; in the middle, the cobblestone malformation with hydrocephalus that
defines this entry; and at the mild end, an adult-onset leukoencephalopathy
in which cortical dysgenesis was explicitly absent. The entry's genetic
notes describe the truncating-versus-hypomorphic gradient as "emerging",
which is the right hedge — the whole reported cohort was about eleven
patients and eleven variants, far too small to establish a
genotype-phenotype rule, and it does not explain how a biallelic LAMB1
genotype can spare the cortical malformation entirely. Whether the
determinant is residual laminin beta-1 function, compensating laminin
chains, modifier background, or developmental timing of pial
basement-membrane assembly is unresolved. This is the disease-level instance
of the non-one-to-one gene-to-phenotype mapping that the cortical
malformation review flags as a general gap for malformations of cortical
development, and it bounds what this entry may claim: the cobblestone
malformation is not an obligate consequence of biallelic LAMB1 loss.
evidence:
- reference: PMID:37466007
reference_title: "Novel homozygous LAMB1 in-frame deletion in a pediatric patient with brain anomalies and cerebrovascular event."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Pathogenic variants in LAMB1 are rare, with only 11 pathogenic variants
and 11 patients reported to date.
explanation: >-
Quantifies the cohort the genotype-phenotype correlation rests on, which
is too small to support a rule.
- reference: PMID:33542858
reference_title: "Biallelic Variants in LAMB1 Causing Hydranencephaly: A Severe Phenotype of a Rare Malformative Encephalopathy."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Herein we present LAMB1 as a monogenic cause of fetal hydranencephaly
which was incompatible with life.
explanation: Establishes the lethal severe extreme of the LAMB1 spectrum.
- reference: PMID:32548278
reference_title: "Adult-onset leukoencephalopathy with homozygous LAMB1 missense mutation."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Brain MRI showed diffuse T2 hyperintensity of cerebral white matter, but
neither cortical dysgenesis nor cystic lesions were observed
explanation: >-
Establishes the mild extreme, in which a biallelic LAMB1 genotype produced
no cobblestone cortical malformation at all.
proposed_experiments:
- experiment_id: exp_lamb1_genotype_stratified_registry_and_residual_function
name: Genotype-stratified LAMB1 registry with residual laminin beta-1 function assay
description: >-
Assemble a multi-centre registry of all biallelic LAMB1 cases with
standardised fetal and postnatal neuroimaging review, and pair each
genotype with a quantitative assay of residual laminin beta-1 protein and
heterotrimer assembly in patient fibroblasts or iPSC-derived cells. Test
whether measured residual function, rather than variant class alone,
separates the hydranencephaly, cobblestone, and isolated-leukoencephalopathy
presentations, and whether laminin beta-2 upregulation tracks with the
milder outcomes.
experiment_type:
preferred_term: genotype-stratified natural history study with functional assay
decision_criterion: >-
The correlation is established if residual laminin beta-1 function
separates the three presentation classes with no overlap; it is refuted if
patients with indistinguishable residual function fall on opposite ends of
the cortical-malformation spectrum, which would point to modifiers or
developmental timing instead.
Overview. LAMB1-related cobblestone lissencephaly is an ultra-rare autosomal recessive neuronal migration disorder caused by biallelic pathogenic variants in LAMB1 (laminin subunit beta-1, chromosome 7q31.1). It belongs to the "cobblestone" (Type II) lissencephaly spectrum — malformations in which overmigration of neurons and glia through breaches in the pial basement membrane produces an irregular, pebbled cortical surface, in contrast to classical (Type I) lissencephaly caused by undermigration (e.g., LIS1, DCX). Unlike the prototypical cobblestone disorders (muscle-eye-brain disease, Walker-Warburg syndrome, Fukuyama congenital muscular dystrophy), which arise from defective α-dystroglycan glycosylation and feature prominent muscular dystrophy and ocular malformations, LAMB1-related disease was specifically distinguished by the founding report as "cobblestone brain malformation without muscular or ocular abnormalities" (Radmanesh et al., 2013, PMID: 23472759) — patients have normal creatine phosphokinase, normal EMG/nerve conduction studies, and no clinical myopathy.
Key identifiers: - OMIM: #615191 — "Leukoencephalopathy with Variable Cortical Brain Malformations and/or Hydrocephalus" (LKBMH); gene locus LAMB1, OMIM 150240 - MONDO: MONDO:0014077 (cobblestone lissencephaly without muscular or ocular involvement) - Orphanet: ORPHA:352682 (gene-disease association page: LAMB1) - HGNC: HGNC:6486 (LAMB1) - UniProt: P07942 (Laminin subunit beta-1) - GTR condition ID:* C3554657
Synonyms/alternative names: Lissencephaly 5 (LIS5); cobblestone brain malformation without muscular or ocular abnormalities; LAMB1-related leukoencephalopathy; cystic leukoencephalopathy with cortical dysplasia (a phenotypic variant name).
Evidence base: All data derive from individual case reports and small case series (aggregated across ~11+ published pathogenic variants and a similarly small number of kindreds as of the most recent counts), not large disease registries — this is one of the rarest laminin-related human disorders known, with only a handful of families reported worldwide since the first description in 2013.
Sources: Orphanet: LAMB1; OMIM #615191; PMC3591846; GTR C3554657
Disease causal factor: Purely genetic/mechanistic — biallelic (homozygous or compound heterozygous) loss-of-function or severely hypomorphic variants in LAMB1, encoding laminin β1, an obligate structural subunit of basement membrane laminin heterotrimers (laminin-111, -121, -211, etc.).
Genetic risk factors: - Consanguinity is a major risk factor — nearly all reported cobblestone-phenotype families are from consanguineous unions (Egyptian and Turkish families in the index report; additional Middle Eastern/Asian consanguineous kindreds in follow-up reports), consistent with autosomal recessive transmission of rare founder/private alleles. - Variant severity is the principal genotype-phenotype modifier: frameshift/nonsense/canonical splice-site (complete loss-of-function) alleles produce the most severe, congenital-onset cobblestone/hydrocephalic phenotype; missense or in-frame alleles produce milder, sometimes later-onset leukoencephalopathy. - A distinct monoallelic (heterozygous), presumed toxic gain-of-function mechanism has also been proposed for adult-onset leukoencephalopathy, separate from the classical recessive cobblestone syndrome (Faundes et al., 2025, DOI: 10.1007/s10048-025-00872-1).
Environmental/other risk factors: None established — this is a monogenic structural brain malformation with no known environmental, infectious, or lifestyle contribution.
Protective factors: None documented; no protective alleles or modifier loci have been reported given the extreme rarity of the condition.
Gene-environment interactions: Not applicable/not studied — no epidemiological cohort exists of sufficient size to examine G×E effects.
Sources: PMC3591846; Neurogenetics 2025 continuum paper
Suggested HP terms are given for each.
Neurodevelopmental / cognitive: - Severe global developmental delay (HP:0011344) — present in essentially all congenital-onset cases - Intellectual disability, severe (HP:0010864) - In the mild adult-onset variant: borderline intellectual functioning only (full-scale IQ 69 reported in one 37-year-old patient) (PMID: 32548278)
Neurological signs: - Seizures/epilepsy (HP:0001250) — common in congenital cases - Macrocephaly / increased head circumference (HP:0000256) in infancy, often from hydrocephalus - Microcephaly (HP:0000252) reported in at least one case with severe cerebellar/cortical involvement (in-frame deletion case, PMID: 37466007) - Spasticity / hyperreflexia (HP:0001257, HP:0001347) — jaw-jerk and lower-limb hyperreflexia, spasticity in adult-onset form - Gait disturbance/ataxia (HP:0001288) — progressive in adult-onset form, onset ~age 31 in the reported case - Migraine (HP:0002076) — earliest symptom (age 22) in the adult-onset case
Structural brain malformations (via neuroimaging, HPO under "Abnormal cerebral cortex morphology"): - Cobblestone cortical malformation / cortical dysplasia (HP:0002536, lissencephaly) - Subcortical band heterotopia (HP:0007260) — "beaded" heterotopic band ~1 cm below cortex - Cerebellar hypoplasia/dysplasia (HP:0007360) — severe, affecting hemispheres and vermis - Brainstem hypoplasia (HP:0002365) - Hydrocephalus (HP:0000238) — sometimes congenital/in utero, requiring shunting by infancy - Occipital encephalocele (HP:0002085) — reported in all three affected siblings of one family - Agenesis/hypoplasia of corpus callosum (HP:0006989 / HP:0002079) - Periventricular/diffuse leukoencephalopathy or leukodystrophy (HP:0002352/HP:0002469) — white matter T2 hyperintensity - Cystic cerebellar or cerebral white-matter lesions (HP:0002518) — "bilateral cerebellar cysts" phenotype (PMID: 29888467) - Polymicrogyria/gyral simplification (HP:0002536) in milder cases - Cerebrovascular event/perinatal stroke (HP:0002140) in at least one case
Ophthalmologic (mild, distinguishing from classical dystroglycanopathy cobblestone disease): - Optic atrophy, mild/diffuse (HP:0000648) in older affected siblings only - Retinal vessel tortuosity ("mild flexion of retinal vessels") in the adult-onset case
Explicitly ABSENT features (important negative phenotypes distinguishing this entity): - No muscular dystrophy/myopathy (normal CPK, normal EMG/NCS) — absence of HP:0003198 (myopathy) - No major structural eye malformation (retinal detachment, cataract, microphthalmia typical of Walker-Warburg/MEB) beyond mild optic/vascular changes
Phenotype spectrum and progression: The condition spans a severity continuum tied to variant type — from prenatal/neonatal presentation with hydrocephalus and encephalocele (most severe, biallelic null alleles), through infantile/childhood cobblestone lissencephaly with developmental delay and epilepsy, to a cystic leukoencephalopathy with cortical dysplasia intermediate phenotype (PMID: 25925986), to a mild, adult-onset leukoencephalopathy with migraine, gait disturbance, and cognitive decline beginning in the third decade (PMID: 32548278). Course is generally static/non-progressive early (congenital malformation) though the adult-onset form is progressive. There is no reported spontaneous remission.
Quality of life impact: Congenital cases carry profound, lifelong disability (severe DD/ID, medically refractory epilepsy, dependence on shunt/feeding support); no formal EQ-5D/SF-36/PROMIS data exist for this ultra-rare condition.
Causal gene: LAMB1 (laminin subunit beta-1; HGNC:6486; chromosome 7q31.1; OMIM *150240; UniProt P07942). The gene spans ~80 kb with 34 exons.
Reported pathogenic variants (illustrative, not exhaustive — total reported pathogenic variants remain in the low double digits):
| Variant | Type | Zygosity | Source family/case | Predicted effect |
|---|---|---|---|---|
| c.3145_3158delins41 (exon 22) | Complex indel (14bp del/41bp ins, triplicated 19bp repeat) | Homozygous | Egyptian family ("520") | Frameshift, p.Lys1049Profs*7 |
| c.2110+1G>T (intron 16) | Canonical splice-site | Homozygous | Turkish family ("1257") | Splice failure, frameshift p.Ser703fs*62 |
| c.1378T>C | Missense | Homozygous | Adult-onset case (consanguineous) | p.Cys460Arg, disrupts a cysteine in an EGF-like domain |
| Exon 23–24 in-frame deletion (104 aa, removing EGF-like units 11–12 of Domain III) | In-frame deletion | Homozygous | Pediatric case with cerebrovascular event | Loss of two EGF-like repeats; first reported in-frame deletion |
| c.2690+1G>A | Splice-site | Compound heterozygous (with POMGNT1 variants in a multi-gene prenatal cohort) | Chinese fetus, prenatal WES | Novel splice variant, first reported in China |
| c.2270A>C (p.Asn757Thr); c.4188+1G>C | Missense; splice | — | ClinVar-deposited cases | Classified "Cobblestone lissencephaly without muscular or ocular involvement" |
| End-truncated (NMD-escaping) variants | Truncating (non-NMD) | Heterozygous | Cerebral small-vessel disease cohort (n=258) | Cytosolic protein trapping; genome-wide significant association (p<5×10⁻⁸) with CSVD + hippocampal memory defect |
Variant classification (ACMG/ClinVar): Reported variants are generally classified Pathogenic/Likely Pathogenic; absent from gnomAD/1000 Genomes/ExAC/dbSNP and ethnically matched control panels (200 controls in the index study). LAMB1 is intolerant of biallelic loss-of-function (recessive-disease gene model); population allele frequency data for specific pathogenic alleles are essentially null (private/founder variants in each kindred).
Functional consequences: Predominantly loss-of-function (frameshift, nonsense, canonical splice-disrupting) in the classical cobblestone phenotype; missense/in-frame variants produce partial loss-of-function/hypomorphic effects correlating with milder disease. The rare end-truncated, NMD-escaping variants associated with adult small-vessel disease/hippocampal memory defect are hypothesized to act via a dominant-negative or toxic-trapping mechanism (mutant protein retained in the cytosol rather than secreted), distinct from simple haploinsufficiency (PMID: 34606115).
Modifier genes: None formally established in humans. A gene-coexpression network analysis in the founding paper identified functionally correlated genes — LAMC3, ZIC1, ZIC2, FLNA, collagen genes, and COL18A1 — suggesting coordinated regulation of basement-membrane/radial-glial genes, but these are not confirmed clinical modifiers (PMID: 23472759).
Epigenetics: No epigenetic mechanism reported for this disorder.
Chromosomal abnormalities: Not a copy-number/chromosomal disorder; standard karyotype and CMA are typically normal — diagnosis requires gene-level sequencing.
Related/allelic genes in the broader cobblestone/dystroglycanopathy pathway (for differential diagnosis, not LAMB1 itself): POMT1, POMT2, POMGNT1, FKTN, FKRP, LARGE1, ISPD, B3GALNT2, GPR56/ADGRG1, and other laminin genes LAMA1, LAMA2, LAMB2, LAMC3.
No environmental, toxin, lifestyle, or infectious contributors have been identified or are biologically plausible for this basement-membrane structural gene disorder. There is no infectious-agent trigger. This section is not applicable for LAMB1-related cobblestone lissencephaly beyond the genetic etiology above.
Molecular pathway / protein function: Laminin β1 combines with an α chain (e.g., LAMA1, LAMA2) and a γ chain (LAMC1) to form heterotrimeric laminins (e.g., laminin-111), the principal non-collagenous structural components of basement membranes. Laminin β1 is one of the earliest laminin subunits expressed during mammalian development, including in the neuroectoderm, and mediates cell adhesion, migration, and differentiation through interactions with integrins, dystroglycan, and other extracellular matrix components (PMID: 23472759).
Causal chain (upstream → downstream): 1. Upstream trigger: Biallelic loss-of-function LAMB1 variant → failure to produce functional laminin-111/related heterotrimers. 2. Molecular/structural consequence: Disruption of the pial basement membrane / glia limitans (BM/GL), the structure that normally (a) anchors the endfeet of radial glial cells and (b) forms a physical barrier that migrating neurons cannot cross. 3. Cellular consequence: Radial glial endfeet detach from the disintegrated basement membrane; the radial glial scaffold that guides neuronal migration collapses. 4. Tissue consequence: Neurons and neuroglial elements overmigrate past the normal pial boundary into the subarachnoid/leptomeningeal space, producing the irregular "cobblestone" cortical surface, subcortical band heterotopia, and — when the breach is severe/focal at the dorsal midline — encephalocele. 5. Organ-level consequence: Disrupted CSF dynamics from abnormal cortical/leptomeningeal architecture contributes to hydrocephalus; severe cerebellar BM disruption (laminin β1 shows high expression in cerebellar basement membrane in mouse) produces the disproportionately severe cerebellar dysplasia seen clinically.
Direct quote from the foundational mechanistic paper: "radial glia detach, the scaffolding mediating neuronal migration disintegrates, leading to subcortical heterotopia" (PMID: 23472759).
Cellular processes involved: Cell-matrix adhesion, radial glial scaffold maintenance, neuronal migration (radial and possibly tangential), basement membrane assembly.
Protein dysfunction: Predominantly loss of secreted structural function (failure to form intact basement membrane) for truncating alleles; for the rare non-NMD-escaping truncated variant associated with adult CSVD/hippocampal phenotype, the mutant protein is mislocalized/trapped in the cytosol rather than secreted — a distinct "trafficking failure" mechanism (PMID: 34606115).
Tissue damage mechanism: Structural/architectural failure (basement membrane breach) rather than classic oxidative/inflammatory injury; secondary cerebrovascular events have been reported (perinatal cerebrovascular event in one case), possibly reflecting a role for laminin β1 in vascular basement membrane integrity.
Immune system involvement: None described; this is not an inflammatory or autoimmune disease.
Suggested GO terms: - GO:0007155 cell adhesion - GO:0016477 cell migration - GO:0021819 layer formation in cerebral cortex - GO:0021987 cerebral cortex development - GO:0043588 skin development / GO:0030198 extracellular matrix organization - GO:0022008 neurogenesis; GO:0001764 neuron migration - GO:0005605 basement membrane (cellular component)
Suggested CL (Cell Ontology) terms: - CL:0000030 glioblast / radial glial cell (CL:0002619 radial glial cell) - CL:0000117 CNS neuron (migrating cortical neuron) - CL:0002605 astrocyte of the cerebral cortex (as relevant to glia limitans)
Model-system molecular profiling: No transcriptomic/proteomic/single-cell datasets specific to human LAMB1-mutant tissue have been published; mechanistic insight instead comes from mouse and zebrafish Lamb1 loss-of-function models (see Section 15).
Organ level: - Primary organ: Central nervous system — cerebral cortex, cerebellum, brainstem, ventricular system, meninges/calvarium (encephalocele). - Secondary/associated: Peripheral/skeletal muscle and eye are notably spared (the defining negative finding versus classical dystroglycanopathy cobblestone disease); mild optic nerve/retinal vascular changes occur in some patients. - Body systems: Nervous system (primary); no cardiovascular, renal, hepatic, or musculoskeletal system involvement reported as core disease features (though isolated cerebrovascular events occur).
Tissue and cell level: - Cerebral cortex (cortical plate, pial surface) — UBERON:0000956 (cerebral cortex) - Cerebellum — UBERON:0002037 (cerebellum), with hemispheric and vermal dysplasia and cyst formation - Brainstem — UBERON:0002298 - Leptomeninges/pia mater — UBERON:0002360 (pia mater) - Lateral/third ventricles — UBERON:0002285 (ventricular system) — hydrocephalus - Corpus callosum — UBERON:0002336 - Cell populations: radial glial cells (CL:0002619), migrating cortical projection neurons (CL:0000679), Cajal-Retzius cells (implicated in pial BM attachment more broadly), astrocytic endfeet forming the glia limitans
Subcellular level: - Extracellular matrix / basement membrane (GO:0005605) — the principal subcellular/extracellular compartment affected - For the trafficking-defective truncated variant: cytosol (mislocalized protein) rather than the normal secretory/extracellular destination (GO:0005829 cytosol vs. normal ER→Golgi→secretion pathway)
Localization: Cortical malformation is characteristically more severe posteriorly than anteriorly — direct quote: "cortical gyration in the anterior forebrain regions was relatively preserved in comparison with that in the posterior regions" (PMID: 23472759). Encephalocele, when present, is typically occipital (posterior midline). Distribution is generally bilateral/symmetric, consistent with a global basement-membrane structural gene defect rather than a focal/lateralized process.
Onset: - Congenital/prenatal: Classical severe form — intrauterine hydrocephalus detectable on prenatal ultrasound (reported as early as 24 weeks' gestation in a fetal case), occipital encephalocele apparent at birth. - Infantile: Hydrocephalus requiring shunt placement by ~8 months of age in the index family; developmental delay and seizures emerging in infancy/early childhood. - Adult-onset: A distinct, milder end of the spectrum — first symptom (migraine) at age 22, gait disturbance at 31, cognitive decline by 35 in one reported homozygous-missense case. - Onset pattern for the structural malformation itself is prenatal/congenital (a static developmental defect), while functional/neurological manifestations (seizures, spasticity, cognitive decline) can be insidious and progressive, especially in the leukoencephalopathy-predominant and adult-onset forms.
Progression: - The structural cortical malformation is fixed/non-progressive once formed (a developmental field defect). - Neurological function, however, can show a progressive course in a subset of patients — e.g., progressive gait disturbance and cognitive decline over years in the adult-onset case; progressive white-matter signal change reported in some leukoencephalopathy cases. - Disease duration is chronic/lifelong; no self-limited course is described.
Patterns: - No remission pattern is described (this is a structural malformation, not a relapsing-remitting disease). - The prenatal period (neural tube closure through mid-gestation cortical neuronal migration, roughly gestational weeks 6–24) represents the critical developmental window during which laminin β1-dependent glia limitans integrity is required; disruption during this window is causally linked to the malformation, meaning no postnatal intervention can reverse the structural defect (only manage its sequelae).
Epidemiology: No formal prevalence/incidence estimates exist. This is one of the rarest reported human laminin disorders — as of recent reviews, only ~11 pathogenic variants and a similarly small number of affected patients/families had been reported worldwide, spanning publications from 2013–2023+ with additional cases (adult-onset, prenatal, in-frame deletion, CSVD-associated truncating variants) continuing to expand the phenotypic spectrum. No registry-based prevalence (per 100,000) figure is available; it should be considered ultra-rare (likely <1/1,000,000, "not yet documented" in Orphanet epidemiological-class terms).
Inheritance pattern: Autosomal recessive for the classical cobblestone lissencephaly/LKBMH phenotype (confirmed by segregation in consanguineous families). A distinct monoallelic (heterozygous), presumed toxic gain-of-function/dominant-negative mechanism has been proposed separately for adult-onset leukoencephalopathy/cerebral small-vessel disease associated with specific end-truncated variants — i.e., LAMB1 disease may show a dual inheritance model depending on variant class.
Penetrance: Appears complete for biallelic null alleles in the congenital form (all homozygotes in reported consanguineous kindreds were affected). Penetrance/expressivity data for the proposed heterozygous gain-of-function CSVD-associated variants are less well characterized (derived from a case-control genetic-association study rather than a fully penetrant Mendelian pedigree).
Expressivity: Markedly variable, correlating with variant severity — ranging from prenatal lethality-risk hydrocephalus/encephalocele, through childhood cobblestone lissencephaly with epilepsy, to isolated cystic leukoencephalopathy, to adult-onset mild leukoencephalopathy with migraine and late cognitive decline.
Genetic anticipation: Not reported/not applicable (not a repeat-expansion disorder).
Germline mosaicism: Not specifically documented for LAMB1 but cannot be excluded given small numbers.
Founder effects: Each reported pathogenic variant to date appears to be a private, family-specific (often novel) variant rather than a recurrent founder allele, though the strong consanguinity pattern (Egyptian, Turkish, Chinese, and other reported kindreds) reflects population-specific enrichment of rare recessive alleles via consanguinity rather than a single shared founder mutation.
Consanguinity: A major and recurring risk factor — the index families were first-cousin unions; most subsequent severe congenital cases are also from consanguineous backgrounds.
Carrier frequency: Unknown/not established (variants are private, so no meaningful population carrier-frequency estimate exists in gnomAD or similar databases).
Population demographics: Reported cases span Middle Eastern (Egyptian, Turkish, Iranian-adjacent), East Asian (Chinese), and other ancestries — no specific ethnic predisposition beyond the consanguinity-driven recessive-disease pattern. No confirmed sex ratio skew (autosomal gene, both sexes affected in reported pedigrees). No specific geographic endemicity beyond scattered case reports.
Laboratory tests: Largely normal/non-contributory for the core cobblestone phenotype — a key diagnostic feature is normal creatine phosphokinase (CPK), which helps exclude the α-dystroglycanopathies (Walker-Warburg, MEB, Fukuyama) that classically present with markedly elevated CPK.
Biomarkers: None specific; no validated circulating biomarker for LAMB1 disease.
Imaging (the primary diagnostic modality): - Brain MRI is central: shows the cobblestone cortical pattern, subcortical band-like heterotopia, cerebellar dysplasia/cysts, brainstem hypoplasia, white-matter T2 hyperintensity/leukoencephalopathy, hydrocephalus, and (in some) occipital encephalocele or corpus callosum abnormality. - Prenatal ultrasound can detect hydrocephalus, ventricular dilation, and corpus callosum agenesis as early as the second trimester (~24 weeks), prompting prenatal exome sequencing in some reported cases.
Functional tests: Electromyography (EMG) and nerve conduction studies are normal — used to exclude the myopathic component of classical dystroglycanopathies.
Electrophysiology: EEG for seizure characterization in symptomatic patients (no LAMB1-specific EEG signature reported).
Biopsy/histopathology: Muscle biopsy, when performed, shows no dystrophic changes (distinguishing from α-dystroglycanopathy); brain histopathology is rarely available (not routinely biopsied) — the disease is essentially a radiographic/genetic diagnosis.
Genetic testing: - First-line approach: Given the rarity and phenotypic overlap with the α-dystroglycanopathy cobblestone spectrum, a gene panel for cobblestone lissencephaly/congenital muscular dystrophy-dystroglycanopathy (including LAMB1, POMT1/2, POMGNT1/2, FKTN, FKRP, LARGE1, ISPD, B3GALNT2, GPR56, LAMA1/2, LAMC3) or whole-exome/genome sequencing is recommended, particularly when CPK is normal (arguing against classical dystroglycanopathy). - Chromosomal microarray (CMA)/karyotype: Typically normal; used to exclude copy-number or chromosomal causes of the malformation before proceeding to single-gene/panel/exome testing. - Prenatal diagnosis: Demonstrated feasible via prenatal whole-exome sequencing when ultrasound identifies congenital hydrocephalus/corpus callosum agenesis (PMID: 35843586). - Mitochondrial DNA testing, repeat-expansion testing: Not relevant to this disorder.
Omics-based diagnostics: Not part of routine diagnostic workup; research-level exome/genome sequencing has been the actual diagnostic method in essentially all reported cases (this is fundamentally a "next-generation sequencing–discovered" disease entity).
Clinical/differential diagnosis: Must be distinguished from the α-dystroglycanopathy cobblestone lissencephalies (Walker-Warburg syndrome, muscle-eye-brain disease, Fukuyama CMD) — key distinguishing features are normal CPK, normal EMG/NCS, absence of significant ocular malformation, and absence of clinically apparent myopathy. Also consider other laminin-related cortical malformation genes (LAMA1, LAMA2, LAMB2, LAMC3) and TUBA1A/tubulinopathy-related cortical malformations.
Screening: No population-based newborn screening exists (not detectable biochemically); carrier screening would require known familial variants given the private-variant nature of the disease; genetic counseling is recommended for consanguineous families with an affected child (25% recurrence risk per pregnancy for autosomal recessive inheritance).
Survival and mortality: No formal survival statistics exist given the extreme rarity; prognosis is guarded for the severe congenital form given profound developmental delay, epilepsy, and hydrocephalus; specific mortality data (e.g., 5-year/10-year survival) have not been published in aggregate.
Morbidity and function: Severe, lifelong neurodevelopmental disability is typical for the congenital cobblestone phenotype — severe intellectual disability, medically managed epilepsy, and motor impairment (spasticity). The milder leukoencephalopathy and adult-onset forms carry comparatively better functional outcomes (borderline cognition, ambulatory with spasticity).
Disease course/complications: Hydrocephalus (managed with shunting), seizures (managed pharmacologically), feeding difficulties (sometimes requiring gastrostomy), and — in at least one reported case — a perinatal cerebrovascular event, suggesting a possible vascular fragility complication in some patients.
Recovery potential: None for the structural malformation itself (a fixed developmental defect); functional gains are possible through supportive/rehabilitative therapies but do not reverse the underlying brain malformation.
Prognostic factors: Variant type/severity is the dominant prognostic factor — biallelic complete loss-of-function alleles predict the most severe, earliest-onset phenotype (hydrocephalus, encephalocele, severe developmental delay); missense/hypomorphic alleles predict milder, later-onset leukoencephalopathy. No molecular prognostic biomarker beyond genotype itself has been validated.
There is no disease-modifying or curative therapy for LAMB1-related cobblestone lissencephaly; management is entirely supportive and symptomatic, as is standard across the cobblestone/lissencephaly spectrum.
Pharmacotherapy: - Antiseizure medications for epilepsy management (agent selection per standard pediatric epilepsy protocols; no LAMB1-specific drug data exist). Suggested NCIT term: NCIT:C15986 (Pharmacotherapy). - No pharmacogenomic data specific to LAMB1 variants and drug metabolism/response have been reported.
Surgical/interventional: - Ventriculoperitoneal (VP) shunting for hydrocephalus (NCIT:C15329, Surgical Procedure / more specifically a CSF-diversion procedure) — used both prenatally-diagnosed and infantile cases. - Encephalocele repair surgery when present. - Epilepsy surgery (resective) may be considered for medically refractory focal epilepsy in select patients, per general lissencephaly management guidance, though not specifically reported for confirmed LAMB1 cases.
Supportive and rehabilitative care: - Multidisciplinary supportive care: nutritional support (including gastrostomy tube feeding in severely affected infants; NCIT:C15447 Dietary Intervention), physical therapy (NCIT:C15302), occupational therapy, and speech therapy (NCIT:C159273) as clinically indicated for motor/developmental impairment. - Genetic counseling (NCIT:C15240) for families, given the 25% recurrence risk in future pregnancies for confirmed carrier parents.
Advanced/experimental therapeutics: No gene therapy, cell therapy, RNA-based therapy (ASO/siRNA), or targeted molecular therapy has been developed or trialed for LAMB1-related disease; no registered clinical trials (ClinicalTrials.gov) specifically target this ultra-rare condition as of current knowledge.
Treatment strategy: Management follows the same multidisciplinary, symptom-directed algorithm used broadly for cobblestone lissencephaly/congenital brain malformation syndromes: address hydrocephalus surgically, control seizures pharmacologically, support nutrition/growth, and provide rehabilitative therapies to maximize functional potential — there is no genotype-guided/personalized treatment pathway at this time.
Primary prevention: Not possible in the traditional sense (no modifiable risk factor); the only actionable primary-prevention lever is genetic counseling and reproductive planning in families with a known pathogenic LAMB1 variant, especially in consanguineous unions.
Secondary prevention/screening: - Prenatal diagnosis via targeted variant testing (if familial variants are known) or prenatal whole-exome sequencing when ultrasound anomalies (hydrocephalus, corpus callosum agenesis) are detected, enabling informed pregnancy management decisions. - Preimplantation genetic diagnosis (PGD) is theoretically available for families with a known pathogenic variant, analogous to other severe autosomal recessive disorders, though no specific report of PGD use for LAMB1 was identified. - Carrier screening is limited by the private/family-specific nature of variants — expanded carrier screening panels including LAMB1 could theoretically be used in high-consanguinity populations, but this is not a currently established practice specific to this gene.
Tertiary prevention: Early recognition and management of hydrocephalus (shunting) and seizures to prevent secondary complications (e.g., seizure-related injury, raised-intracranial-pressure sequelae).
Immunization: Not applicable (non-infectious disease).
Public health/environmental interventions: Not applicable.
Genetic counseling: The central preventive intervention — informing consanguineous families of the recessive 25% recurrence risk and offering prenatal/preimplantation testing options once a familial variant is identified.
Taxonomy: No naturally occurring veterinary disease analog of LAMB1-related cobblestone lissencephaly has been reported in companion animals or livestock (not listed in OMIA to current knowledge).
Orthologous gene: Lamb1 is highly conserved across vertebrates — mouse Lamb1 (NCBI Gene, chromosome 12), zebrafish lamb1a — reflecting the fundamental, ancient role of laminin β1 in basement membrane biology across Metazoa.
Comparative biology: The zebrafish and mouse orthologs demonstrate that laminin β1's role in basement membrane integrity and neuroectodermal/retinal development is deeply evolutionarily conserved (see Model Organisms below); no natural (spontaneous) animal disease model is known, but engineered models recapitulate aspects of the human phenotype.
Zoonotic potential/transmission: Not applicable (monogenic structural disorder, not infectious).
Mouse: - Complete Lamb1 (laminin β1) germline knockout is embryonic lethal at a very early stage. Notably, the closely related α1 chain (Lama1)-deficient mice die around embryonic day E7 due to failure of Reichert's membrane (an extraembryonic basement membrane required for epiblast differentiation) — illustrating that any one laminin chain (α, β, or γ) is required for normal trimeric laminin assembly and that its loss is catastrophic to the earliest basement membranes. Conditional knockout strategies (e.g., Lama1^cko) that spare extraembryonic tissue while deleting the gene in the embryo proper have been used to bypass this early lethality and study laminin function specifically in later embryonic/CNS tissues. - In wild-type mouse brain, laminin β1 immunostaining shows high expression in the cerebellar basement membrane, mechanistically consistent with (and likely explanatory of) the disproportionately severe cerebellar dysplasia observed in human patients (PMID: 23472759). - Related laminin-chain mouse models (Lamb2, Lamc3 double knockouts) directly demonstrate that cortical basement membrane laminins are "critical cortical basement membrane components," and their ablation "disrupts cortical lamination and produces dysplasia" (PMID: 22961762) — mechanistically analogous to the proposed human LAMB1 pathophysiology, since Lamb2/Lamc3-containing laminins occupy a similar structural role in the glia limitans.
Zebrafish: - lamb1 mutant zebrafish display "disintegrated retinal inner limiting membrane and ectopias that protrude into the interstitial space between the retina and the lens" — a retinal basement-membrane phenotype directly analogous (mechanistically) to the cortical basement-membrane/glia-limitans breach proposed in human cobblestone lissencephaly, even though human LAMB1 patients themselves do not show major retinal malformation (PMID: 23472759).
Human cellular models: Patient-derived fibroblasts have been used to demonstrate that an end-truncated, NMD-escaping LAMB1 variant produces a protein that is abnormally trapped in the cytosol rather than properly trafficked/secreted, providing direct human cell-based mechanistic evidence for a trafficking-defect model of pathogenesis distinct from simple loss-of-function (PMID: 34606115).
Model limitations: No mouse or zebrafish model to date fully recapitulates the specific human cobblestone-lissencephaly cortical phenotype (subcortical band heterotopia, encephalocele) with a hypomorphic/patient-equivalent allele — existing rodent knockouts are either embryonic lethal (null) or focus on related laminin chains (Lamb2/Lamc3) rather than Lamb1 itself in a viable postnatal model. This represents a notable model-system gap: the causal chain "LAMB1 loss → glia limitans breach → neuronal overmigration" is well-supported by combined human neuropathological reasoning, mouse expression data, and zebrafish retinal-BM phenotypes, but no single animal model has been shown to reproduce the full human cortical cobblestone malformation.
Applications: These models are primarily useful for studying (1) basement membrane assembly requirements (laminin trimer obligate chain composition), (2) the general "glia limitans breach → neuronal overmigration" mechanism shared across cobblestone lissencephaly genes, and (3) protein-trafficking consequences of specific truncating variants (via patient fibroblasts) — rather than as a full preclinical model for a specific LAMB1 therapeutic candidate, none of which currently exist.
| PMID/Source | Study | Key contribution |
|---|---|---|
| 23472759 | Radmanesh et al., AJHG 2013 | Founding report: LAMB1 causes cobblestone brain malformation without muscular/ocular involvement; mechanism, mouse/zebrafish data |
| 25925986 | Tonduti et al., Neurology 2015 | Cystic leukoencephalopathy with cortical dysplasia phenotype |
| 29888467 | Okazaki et al., Clin Genet 2018 | Bilateral cerebellar cysts phenotype; diagnostic recommendation |
| 32548278 | Neurology Genetics 2020 | Adult-onset mild leukoencephalopathy, homozygous missense variant |
| 35843586 | 2022 | Prenatal WES diagnosis, compound heterozygous LAMB1 in fetal hydrocephalus |
| 34606115 | 2021 | End-truncated LAMB1, cerebral small-vessel disease + hippocampal memory defect, protein-trafficking mechanism |
| 37466007 | Toutouna et al., AJMG 2023 | First in-frame deletion; cerebrovascular event phenotype |
| Faundes et al., Neurogenetics 2025 (DOI 10.1007/s10048-025-00872-1) | 2025 | Proposes recessive-to-dominant phenotypic continuum model |
| OMIM #615191 / *150240 | — | Clinical synopsis, gene-disease relationship reference |
Sources: - Mutations in LAMB1 Cause Cobblestone Brain Malformation without Muscular or Ocular Abnormalities (PMC) - Entry #615191 OMIM - Entry *150240 OMIM - Orphanet: LAMB1 - Adult-onset leukoencephalopathy with homozygous LAMB1 missense mutation (PMC) - Novel homozygous LAMB1 in-frame deletion (PubMed) - Cystic leukoencephalopathy with cortical dysplasia related to LAMB1 mutations (PubMed) - Bilateral cerebellar cysts and cerebral white matter lesions (PubMed) - End-Truncated LAMB1 Causes a Hippocampal Memory Defect and a Leukoencephalopathy (PubMed) - Compound variants of FKTN, POMGNT1, and LAMB1 in prenatal WES (PubMed) - LAMB1-associated leukoencephalopathy: a continuum (R Discovery) - Cobblestone lissencephaly (Type II) case report and literature review (PMC) - GTR: Cobblestone lissencephaly without muscular or ocular involvement - LAMB1 Gene - GeneCards - β2 and γ3 laminins are critical cortical basement membrane components (PubMed)